FDA backs Pfizer COVID-19 boosters for seniors, high-risk


The food and drug administration signed off on the recommendation that seniors and high risk Americans be allowed to get five users cobit booster shot the FDA says eligible Americans who received by users two dose vaccine should get a third dose six months after the last shot they received that would be people age sixty five and older health care workers teachers grocery workers and those in homeless shelters where prisons but it's up to a panel of the U. S. centers for disease control to make specific recommendations about who gets the boosters and when the panel is still hearing various reports including some views that boosters are not needed because the covert vaccines are still warding off severe illness but more people are getting infected as immunity is waning Jackie Quinn Washington

Coming up next